Recently, HER2‐low BC has been suggested as a potentially independent subtype of BC from traditionally HER2‐negative BC [including HER2‐low BC and HER2‐zero BC (IHC of 0)] due to a potential better prognosis.9, 14. Here, ERBB2 is linked to breast cancer.